🚨
we are working with hospitals and labs starting with thousands of patients' records and expanding across clinical notes, imaging, pathology, molecular data and experimental results & we’re just getting started
if you're building Al for bio, would love to chat
also hiring across the team- let’s build together :)
6
🚨🚨🚨
The end game of centralized AI labs is to take their customers' business
~ Mistral's CEO & Co-Founder Arthur Mensch
"If if we end up in a world where all companies need to rely on two or three providers that are centralized AI providers that give them enormous leverage, they will use the data uh that is being produced by the systems to make better systems and to go after the business of their customers, because at the end this is this is the end game. This is pretty clearly what is being priced in today."
----
Full video on "20VC with Harry Stebbings" (@HarryStebbings) YouTube channel, (link in comment)
5
AI DeSci Guy retweeted
New Nvidia + other labs paper shows that irrelevant text hurts mainly by weakening the model's use of the question, not by directly pushing against the right answer.
Prompts in RAG, tool use, and long-context apps often carry text that has nothing to do with the question. Even a line like "Computers are useful" lowers a model's support for the right answer.
They traced this inside open models and found intrusion heads, a small set of attention heads that read the unrelated text and weaken the answer. Masking those heads' attention to the context leaves the heads that use helpful evidence untouched.
Across 4 tasks on 7B-scale models, masking about 10 heads recovered 57% of the accuracy lost to distractors on average. An oracle fix that needs a matching clean run recovered 97.6%.
If you serve open-weight models with noisy retrieved context, a training-free mask on a few model-specific heads can win back much of the lost accuracy.
🧑⚖️✨🕵️♀️💻🧑⚖️✨🕵️♀️💻🧑⚖️✨🕵️♀️💻
Nvidia faces a class action after Jensen Huang admitted an affair with a suspected spy.
The complaint alleges that Jensen Huang had an affair with a suspected Chinese spy who also has a role at Megaspeed, which is suspected of helping China evade export controls, so Nvidia’s statements about its relationship with Megaspeed were materially false and misleading.
Huang’s own words are now evidence too, because the suit lists his October 30, 2026 line to Bloomberg: “We’ve studied all their deployments of our GPUs and counted every one.”
The suit cites a spokesman’s October 29 claim that Huang’s interactions with Alice Huang, a former Megaspeed executive, were “not unusual or unexpected.”
US intelligence reportedly concluded she was recruited by China’s Ministry of State Security, though that hasn’t been publicly proven.
AI DeSci Guy retweeted
Some takeaways after a few months of building an automated lab for tissue manufacturing:
- Software and AI can do a lot of the troubleshooting for you and integrate instruments in ways that weren’t possible before. For advanced OOD workflows, though, the bottleneck quickly becomes hardware (temperature control, dead volumes, latency, etc.).
- As more powerful non-destructive measurement modalities come online, workflows need to accommodate them. Designing and planning for lean processes becomes critical.
- The teams building truly novel simulations cannot be far from the data generation engine. If you come visit us, you’ll find our AI scientists in the lab talking to our tissue engineers.
(P.S. come see some tissues! It is fun!)
AI DeSci Guy retweeted
Paralyzed man walking....brain–spine interface in a man paralyzed by spinal cord injury.
AI decoded his intention to walk and stimulated his spinal cord below the injury.
He regained the ability to stand and walk in everyday settings.
doi.org/10.1038/s41586-023-0…
AI DeSci Guy retweeted
Today we're launching Ordo Labs (YC F26) 🚀
Every medicine you take is tested in a regulated lab, where scientists still analyze data, check QC and write reports by hand.
Ordo does that work for them. In paid pilots, labs cut post-analysis time by 90%+.
Built by @SebApelgren, @kristinahoang_ and @adamtovatt
AI DeSci Guy retweeted
Lots of cancer patients and their caregivers are turning to AI to build tools and services to help track treatments and explore options that their care teams may not have suggested - I wrote about these people going "founder mode" on their cancer for The American Journal of Managed Care: bit.ly/4B4Z4Ai
“Both of my parents each got diagnosed with cancer within a week of each other.”
Ashley is the VP of Product at @OpenAI for Health and this is a very special episode for me. We talked about how we both use AI to help our parents fight cancer — including preparing for doctor visits, researching treatments, and coping with our emotions as caregivers. Topics we discussed:
→ Do doctors mind when patients bring AI research?
→ How ChatGPT caught a risky treatment before it was given
→ How to make time for your parents with a demanding job
Some quotes from Ashley:
“I always felt like there was no more time in the day. Then someone gets sick and you realize what you can make time for and what can drop.”
“You also have to care for yourself as a caregiver. You have to make sure you’re budgeting time for your own mental health.”
“The treatment she was about to be given would have had a really bad contraindication. She narrowly avoided it because she ran it through Chat.”
📌 Watch now: youtu.be/pR7NCYKsA3o
Thanks to our sponsors:
@meetgranola: AI meeting notes that don’t suck granola.ai/peter
@RiversidedotFM: All-in-one AI studio for podcasts and video creators.riverside.com/Peter…
AI DeSci Guy retweeted
NYC With a Muslim Mayor
#ZohranMamdani
Who hired illegals Radical Islamic ☪️ acting as police officers?!!!
WTF?
Fake NYC 🇺🇸 cops arrested by ice
hours after situation
with woman and her dog 🐶 👉🤷♀️
🚨✨
The next gains in AI drug discovery will come from tighter design-to-experiment loops, not bigger models alone.
Our new collaboration with @PierreFabre puts this into action: de novo small-molecule design, tightly coupled with robotic lab feedback in multiple #Oncology programs.
1
36
✨✨✨✨✨✨✨✨✨
Google published a paper that might end the PhD.
It’s called “ScientistTwo”
For centuries, the bottleneck to human knowledge has been the human brain.
It takes five years of grueling labor to read the literature, find a gap, formulate a hypothesis, run the experiments, and write the paper.
But, Google automated the entire pipeline.
They built an AI that reads a problem, forms hypotheses, runs experiments, writes the paper, AND simulates its own peer review. no human touches it.
It reads millions of papers to find blind spots in the current science.
It generates novel hypotheses.
It designs the experiments. It writes the code to test them.
When the code fails, it debugs itself.
When the results come in, it analyzes the data, generates the charts, and writes the final academic paper.
It even simulates a brutal peer-review process to critique and improve its own work before it considers the project finished.
This isn't an LLM summarizing a PDF. This is a fully autonomous digital scientist.
What takes a human candidate half a decade of massive intellectual effort... the AI accomplishes in a fraction of the time, at a fraction of the cost.
The implications are staggering.
If you can spin up 10,000 autonomous researchers overnight, the rate of scientific discovery is about to go vertical. We are moving from artisanal, human-speed research to industrialized knowledge creation.
But it raises an uncomfortable reality for academia.
When an AI can read the literature, design the experiment, execute the code, and write the paper...
What exactly is the human supposed to do?
🚨✨🚨✨🚨✨🚨✨
Ginkgo sold its first autonomous lab to Novo Nordisk — not a paper, a purchase order.
In its Q3 2026 results (5 Nov), Ginkgo said Novo Nordisk selected it to build an autonomous lab at Novo’s new Waltham, Massachusetts R&D site. This is hardware plus software (RAC + Catalyst) going into a pharma’s own U.S. lab — not another services-only CRO story.
Hard readout
→ First announced autonomous-lab sale to a top-tier pharma company
→ CEO Jason Kelly: the U.S. government is now treating autonomous labs as national infrastructure; the Novo deal “sends a signal to all the other companies in the industry”
→ Q3 revenue $28M (−6% year over year); cash, cash equivalents and marketable securities $285M as of 30 Sept 2026
Worth reading when the question is who is actually buying AI-native wet labs, not who is publishing them.
📄 Earnings PR (SEC): sec.gov/Archives/edgar/data/…
🎧 Earnings call: fool.com/earnings/call-trans…
#AIforScience #LabAutomation #Biopharma
10





























